Don’t miss out - Get your tickets early!

Join this FREE WEBINAR presented by Ben Ahn (Thailand).

TOPIC: Understanding Ibogaine: The Science, The Safety, and The Experience

Among psychedelic medicines, ibogaine stands apart. Former Navy SEAL Ben Ahn offers an accessible introduction to what makes it so unusual: what the ibogaine experience involves, and why it appears to reach addiction and deep-seated trauma in ways other psychedelics do not. He also addresses the other side of that potency. Ibogaine demands rigorous medical screening and monitoring, and understanding why is central to understanding the medicine itself. Speaking strictly as an operator and advocate rather than a medical clinician, Ben draws on his work founding an ibogaine retreat centre to offer a grounded, balanced account of both the promise of ibogaine and the responsibilities it carries.

Objectives:

Understand the phases of the ibogaine experience and what distinguishes it from classical psychedelics.
Explore why ibogaine's unique pharmacological profile allows it to address addiction and entrenched trauma where single-target compounds may not.
Cover how ibogaine is thought to support the brain's recovery from the effects of dependence and trauma.
Outline the medical risks associated with ibogaine and why thorough screening, monitoring, and qualified supervision are essential.
Discover the extended recovery and integration window that follows an ibogaine session, and what it means for lasting change.

EVENT DETAILS

DATE: 19th August 2026
TIME: 11:55am AEST for 12:00pm start, finishing at 1:15pm
DURATION: 75 minutes
LOCATION: Online - a link will be emailed to you with the viewing details

ABOUT THE PRESENTER

Ben Ahn
Ibogaine Retreat Founder & Bwiti Initiate

Ben Ahn is the founder of Nomena, an ibogaine retreat in Southeast Asia, and an advocate for the responsible, medically supervised use of ibogaine. A graduate of the U.S. Naval Academy, Ben served as a Navy SEAL, deploying to Iraq with SEAL Team 3, before transitioning to a corporate career that spanned more than fifteen years with Fortune 500 industrial companies. In his final role, he led international sales and business development across Asia, the Middle East, Europe, India, and Africa as a Division Vice President.

Ben now supports people from many walks of life through their own journeys of deep emotional release, reconnection with their authentic self, and profound shifts in awareness. He is certified in psychedelic-assisted therapy and was formally initiated into the Bwiti Missoko Miobé lineage by a Nima na Kombo (high priest) of the Babongo, the indigenous Gabonese forest people credited as the originators of Bwiti and iboga use.

---

MEDICINAL PSYCHEDELIC TREATMENTS

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

SUPPORT PSYCHEDELIC RESEARCH AND THERAPY DEVELOPMENT

Your donation to Mind Medicine Australia will help us accelerate the availability and best practice of psychedelic-assisted psychotherapy in Australia. We are a small organisation doing big things – we need your support. Please click here to make a tax-deductible donation.

DISCLAIMER

Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms i.e. Facebook, Instagram or zoom private and public chat forms during the webinar. Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters. Mind Medicine Australia is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for certain mental illnesses.

Contact the host of Mind Medicine Australia Global Webinar - Ben Ahn (Thailand): Understanding Ibogaine: The Science, The Safety, and The Experience